Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/32926
Title: | Sphingosine-1-Phosphate Receptor Modulators and Oligodendroglial Cells: Beyond Immunomodulation | Authors: | Roggeri, Alessandra SCHEPERS, Melissa TIANE, Assia ROMBAUT, Ben VAN VEGGEL, Lieve HELLINGS, Niels Prickaerts, Jos Pittaluga, Anna VANMIERLO, Tim |
Issue Date: | 2020 | Publisher: | MDPI | Source: | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 21 (20) (Art N° 7537) | Abstract: | Multiple sclerosis (MS) is an autoimmune inflammatory disease characterized by demyelination, axonal loss, and synaptic impairment in the central nervous system (CNS). The available therapies aim to reduce the severity of the pathology during the early inflammatory stages, but they are not effective in the chronic stage of the disease. In this phase, failure in endogenous remyelination is associated with the impairment of oligodendrocytes progenitor cells (OPCs) to migrate and differentiate into mature myelinating oligodendrocytes. Therefore, stimulating differentiation of OPCs into myelinating oligodendrocytes has become one of the main goals of new therapeutic approaches for MS. Different disease-modifying therapies targeting sphingosine-1-phosphate receptors (S1PRs) have been approved or are being developed to treat MS. Besides their immunomodulatory effects, growing evidence suggests that targeting S1PRs modulates mechanisms beyond immunomodulation, such as remyelination. In this context, this review focuses on the current understanding of S1PR modulators and their direct effect on OPCs and oligodendrocytes. | Notes: | Vanmierlo, T (corresponding author), Hasselt Univ, Biomed Res Inst, Neuroimmune Connect & Repair Lab, B-3500 Hasselt, Belgium.; Vanmierlo, T (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, European Grad Sch Neurosci, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands. roggeri@difar.unige.it; melissa.schepers@uhasselt.be; assia.tiane@uhasselt.be; ben.rombaut@uhasselt.be; lieve.vanveggel@uhasselt.be; niels.hellings@uhasselt.be; jos.prickaerts@maastrichtuniversity.nl; pittalug@difar.unige.it; tim.vanmierlo@uhasselt.be |
Other: | Vanmierlo, T (corresponding author), Hasselt Univ, Biomed Res Inst, Neuroimmune Connect & Repair Lab, B-3500 Hasselt, Belgium ; Maastricht Univ, Sch Mental Hlth & Neurosci, European Grad Sch Neurosci, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands. roggeri@difar.unige.it; melissa.schepers@uhasselt.be; assia.tiane@uhasselt.be; ben.rombaut@uhasselt.be; lieve.vanveggel@uhasselt.be; niels.hellings@uhasselt.be; jos.prickaerts@maastrichtuniversity.nl; pittalug@difar.unige.it; tim.vanmierlo@uhasselt.be | Keywords: | Sphingosine-1-phosphate receptor modulators;OPC;oligodendrocyte;demyelination;multiple sclerosis | Document URI: | http://hdl.handle.net/1942/32926 | ISSN: | 1661-6596 | e-ISSN: | 1422-0067 | DOI: | 10.3390/ijms21207537 | ISI #: | WOS:000582999000001 | Rights: | © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2021 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ijms-21-07537.pdf | Published version | 775.58 kB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
19
checked on Oct 12, 2024
Page view(s)
32
checked on Jul 15, 2022
Download(s)
4
checked on Jul 15, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.